NMP-7

From Wikipedia, the free encyclopedia
Jump to: navigation, search
NMP-7
NMP-7 structure.png
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
Formula C23H28N2O
Molar mass 348.480 g/mol
3D model (Jmol)

NMP-7 is a drug which acts as both a non-selective agonist of the CB1 and CB2 cannabinoid receptors, and also as a blocker of T-type calcium channels, the target of anticonvulsant drugs such as ethosuximide. NMP-7 has an agonist EC50 of 96.9nM at CB1 and 10.5nM at CB2, and an IC50 of 1.84μM for blocking Cav3.2 T-type calcium channels. In animal studies it produces potent analgesic effects in a variety of different tests.[1]


References[edit]

  1. ^ You H, Gadotti VM, Petrov RR, Zamponi GW, Diaz P. Functional characterization and analgesic effects of mixed cannabinoid receptor/T-type channel ligands. Molecular Pain. 2011 Nov 17;7:89. PMID 22093952